UB Paderborn / Katalog / Suche / in CDI

Plasma ApoE elevations are associated with NAFLD: The PREVEND Study

PloS one, 2019-08, Vol.14 (8), p.e0220659-e0220659

2019

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein

PloS one, 2012-06, Vol.7 (6), p.e39110-e39110

2012

Link zum Volltext

Verfügbarkeit prüfen

Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk

International journal of molecular sciences, 2019-02, Vol.20 (4), p.977

2019

Link zum Volltext

Verfügbarkeit prüfen

Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein

Journal of clinical medicine, 2019-09, Vol.8 (9), p.1357

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammation reduces HDL protection against primary cardiac risk

European journal of clinical investigation, 2010-06, Vol.40 (6), p.483-489

2010

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels

PloS one, 2013-07, Vol.8 (7), p.e68920-e68920

2013

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study

Journal of clinical lipidology, 2016-07, Vol.10 (4), p.842-850

2016

Link zum Volltext

Verfügbarkeit prüfen

Chronic Kidney Disease Prevalence and Rate of Diagnosis

The American journal of medicine, 2007-11, Vol.120 (11), p.981-986

2007

Link zum Volltext

Verfügbarkeit prüfen

Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and C-reactive protein using Bayesian network modeling

Data in brief, 2016-09, Vol.8, p.98-104

2016

Link zum Volltext

Verfügbarkeit prüfen

Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation

Atherosclerosis, 2016-07, Vol.250, p.1-8

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients

Arteriosclerosis, thrombosis, and vascular biology, 2008-03, Vol.28 (3), p.548

2008

Link zum Volltext

Verfügbarkeit prüfen

Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects

Clinical biochemistry, 2018-02, Vol.52, p.67-72

2018

Link zum Volltext

Verfügbarkeit prüfen

Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation

International journal of inflammation, 2012-01, Vol.2012, p.678190-13

2012

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling

Clinical biochemistry, 2018-09, Vol.59, p.31-36

2018

Link zum Volltext

Verfügbarkeit prüfen

Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production

American journal of physiology: endocrinology and metabolism, 2000-11, Vol.279 (5), p.E1003-E1011

2000

Link zum Volltext

Verfügbarkeit prüfen

Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels

Arteriosclerosis, thrombosis, and vascular biology, 2010-08, Vol.30 (8), p.1657

2010

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants

Journal of the American Society of Nephrology, 2014-12, Vol.25 (12), p.2906-2915

2014

Link zum Volltext

Verfügbarkeit prüfen

High-density lipoproteins: taking the good with the bad

Current opinion in lipidology, 2014-06, Vol.25 (3), p.230-232

2014

Link zum Volltext

Verfügbarkeit prüfen

Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels

Thrombosis and haemostasis, 2011-12, Vol.106 (6), p.1170

2011

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein

Metabolism, clinical and experimental, 2012-07, Vol.61 (7), p.996-1002

2012

Link zum Volltext

Verfügbarkeit prüfen

An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients

Vox sanguinis, 2011-07, Vol.101 (1), p.55-60

2011

Link zum Volltext

Verfügbarkeit prüfen

NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients

Atherosclerosis, 2008-01, Vol.196 (1), p.461-468

2008

Link zum Volltext

Verfügbarkeit prüfen

Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation

Atherosclerosis, 2006-07, Vol.187 (1), p.191-197

2006

Link zum Volltext

Verfügbarkeit prüfen

Glycerol as a reference material for fecal fat quantitation using low-resolution time domain 1H NMR spectroscopy

Clinical biochemistry, 2011-11, Vol.44 (16), p.1352-1354

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats

Atherosclerosis, 2000-02, Vol.148 (2), p.231-241

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Plasma ApoE elevations are associated with NAFLD: The PREVEND Study

Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein

Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk

Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein

Inflammation reduces HDL protection against primary cardiac risk

Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels

Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study

Chronic Kidney Disease Prevalence and Rate of Diagnosis

Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and C-reactive protein using Bayesian network modeling

Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation

Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients

Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects

Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation

Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling

Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production

Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels

Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants

High-density lipoproteins: taking the good with the bad

Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels

Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein

An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients

NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients

Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation

Glycerol as a reference material for fecal fat quantitation using low-resolution time domain 1H NMR spectroscopy

Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats

Suchergebnisse filtern